PLoS ONE (Jan 2022)

Itemization difference of patient-reported outcome in patients with chronic liver disease

  • Ming-Chieh Lin,
  • Chia-Yen Dai,
  • Chung-Feng Huang,
  • Ming-Lun Yeh,
  • Yi-Chan Liu,
  • Po-Yao Hsu,
  • Yu-Ju Wei,
  • Pei-Lun Lee,
  • Ching-I Huang,
  • Po-Cheng Liang,
  • Ming-Yen Hsieh,
  • Meng-Hsuan Hsieh,
  • Tyng-Yuan Jang,
  • Zu-Yau Lin,
  • Jee-Fu Huang,
  • Ming-Lung Yu,
  • Wan-Long Chuang

Journal volume & issue
Vol. 17, no. 2

Abstract

Read online

Background and aims The itemization difference of patient-reported outcome (PRO) in hepatitis patients with different etiologies remains elusive in Asia. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients. Methods We conducted the study in an outpatient setting. The 36-Item Short Form Health Survey (SF-36) was completed by the patients upon the initial diagnosis and recruitment for a long-term follow-up purpose. The PRO results were also assessed by disease severity. Results There were 244 patients (198 males) of CHB, 54 patients (29 males) of CHC, and 129 patients (85 males) of NAFLD, respectively. CHC patient had the mean score of 67.1 ± 23.3 in physical component summary (PCS) of the SF-36 health survey, which was significantly lower than CHB patients (76.4 ± 19.5), and NAFLD patients (77.5 ± 13.7), respectively (p = 0.001). The significantly lower performance of PCS in CHC patients was mainly attributed to the lower performance in physical functioning and bodily pain components. Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups. There was no significant difference of mean mental component summary (MCS) between groups. However, NAFLD patients had significantly lower mental health scores than other groups (p = 0.02). Conclusions The significant difference of HRQoL exists in hepatitis patients with different etiologies. Disease severity leads to a lower PCS performance.